WO2000058340A3 - 50 proteines humaines secretees - Google Patents

50 proteines humaines secretees Download PDF

Info

Publication number
WO2000058340A3
WO2000058340A3 PCT/US2000/007724 US0007724W WO0058340A3 WO 2000058340 A3 WO2000058340 A3 WO 2000058340A3 US 0007724 W US0007724 W US 0007724W WO 0058340 A3 WO0058340 A3 WO 0058340A3
Authority
WO
WIPO (PCT)
Prior art keywords
secreted proteins
human secreted
proteins
novel human
relates
Prior art date
Application number
PCT/US2000/007724
Other languages
English (en)
Other versions
WO2000058340A2 (fr
Inventor
Craig A Rosen
Steven M Ruben
George Komatsoulis
Original Assignee
Human Genome Sciences Inc
Craig A Rosen
Steven M Ruben
George Komatsoulis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc, Craig A Rosen, Steven M Ruben, George Komatsoulis filed Critical Human Genome Sciences Inc
Priority to CA002368469A priority Critical patent/CA2368469A1/fr
Priority to AU39131/00A priority patent/AU3913100A/en
Priority to JP2000608040A priority patent/JP2003535571A/ja
Publication of WO2000058340A2 publication Critical patent/WO2000058340A2/fr
Priority to US10/105,299 priority patent/US7368527B2/en
Priority to US10/670,185 priority patent/US20070015162A1/en
Priority to US10/670,186 priority patent/US20070031842A1/en
Publication of WO2000058340A3 publication Critical patent/WO2000058340A3/fr
Priority to US10/868,184 priority patent/US20070048818A1/en
Priority to US10/994,608 priority patent/US20070048297A1/en
Priority to US11/781,665 priority patent/US20070298491A1/en
Priority to US12/753,401 priority patent/US8410248B2/en
Priority to US13/848,789 priority patent/US20130203164A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne de nouvelles protéines humaines sécrétées et des acides nucléiques isolés contenant les zones de codage des gènes codant ces protéines. L'invention concerne également des vecteurs, des cellules hôtes, des anticorps et des méthodes de recombinaison permettant de produire des protéines humaines sécrétées. L'invention se rapporte en outre à des méthodes diagnostiques et thérapeutiques utiles dans le diagnostic et le traitement de maladies, de troubles, et/ou d'états pathologiques liés à ces nouvelles protéines humaines sécrétées.
PCT/US2000/007724 1999-03-12 2000-03-23 50 proteines humaines secretees WO2000058340A2 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
CA002368469A CA2368469A1 (fr) 1999-03-26 2000-03-23 50 proteines humaines secretees
AU39131/00A AU3913100A (en) 1999-03-26 2000-03-23 50 human secreted proteins
JP2000608040A JP2003535571A (ja) 1999-03-26 2000-03-23 ５０個のヒト分泌タンパク質
US10/105,299 US7368527B2 (en) 1999-03-12 2002-03-26 HADDE71 polypeptides
US10/670,186 US20070031842A1 (en) 1999-03-12 2003-09-25 379 human secreted proteins
US10/670,185 US20070015162A1 (en) 1999-03-12 2003-09-25 99 human secreted proteins
US10/868,184 US20070048818A1 (en) 1999-03-12 2004-06-16 Human secreted proteins
US10/994,608 US20070048297A1 (en) 1999-03-12 2004-11-23 Human secreted proteins
US11/781,665 US20070298491A1 (en) 1999-03-12 2007-07-23 Human Secreted Proteins
US12/753,401 US8410248B2 (en) 1999-03-12 2010-04-02 HWBAO62 polypeptides
US13/848,789 US20130203164A1 (en) 1999-03-12 2013-03-22 Human Secreted Proteins

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US12651099P 1999-03-26 1999-03-26
US60/126,510 1999-03-26
US17485000P 2000-01-07 2000-01-07
US60/174,850 2000-01-07

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2000/007723 Continuation-In-Part WO2000058357A1 (fr) 1999-03-12 2000-03-23 50 proteines humaines secretees
PCT/US2000/014929 Continuation-In-Part WO2000077173A1 (fr) 1999-03-12 2000-06-01 42 proteines humaines secretees

Related Child Applications (4)

Application Number Title Priority Date Filing Date
PCT/US2000/007723 Continuation-In-Part WO2000058357A1 (fr) 1999-03-12 2000-03-23 50 proteines humaines secretees
PCT/US2000/007722 Continuation-In-Part WO2000058496A1 (fr) 1999-03-12 2000-03-23 50 proteines humaines secretees
US95008301A Continuation-In-Part 1999-03-12 2001-09-12
US95008201A Continuation-In-Part 1999-03-12 2001-09-12

Publications (2)

Publication Number Publication Date
WO2000058340A2 WO2000058340A2 (fr) 2000-10-05
WO2000058340A3 true WO2000058340A3 (fr) 2004-05-21

Family

ID=26824745

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/007724 WO2000058340A2 (fr) 1999-03-12 2000-03-23 50 proteines humaines secretees

Country Status (4)

Country Link
JP (1) JP2003535571A (fr)
AU (1) AU3913100A (fr)
CA (1) CA2368469A1 (fr)
WO (1) WO2000058340A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020173028A1 (en) * 2001-02-16 2002-11-21 Rosana Kapeller-Libermann 23565, a novel human zinc carboxypeptidase family member and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998014568A1 (fr) * 1996-10-01 1998-04-09 Rappold Hoerbrand Gudrun Gene de la croissance chez l'homme et zone du gene de l'insuffisance staturale

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998014568A1 (fr) * 1996-10-01 1998-04-09 Rappold Hoerbrand Gudrun Gene de la croissance chez l'homme et zone du gene de l'insuffisance staturale

Also Published As

Publication number Publication date
CA2368469A1 (fr) 2000-10-05
JP2003535571A (ja) 2003-12-02
WO2000058340A2 (fr) 2000-10-05
AU3913100A (en) 2000-10-16

Similar Documents

Publication Publication Date Title
EP1053245A4 (fr) 45 proteines humaines secretees
WO1998039446A3 (fr) 70 proteines humaines secretees
WO1998039448A3 (fr) 186 nouvelles proteines secretees
WO1998040483A3 (fr) 28 proteines secretees par l'homme
WO1998031800A3 (fr) Proteines humaines
WO2001036432A3 (fr) 18 proteines secretees humaines
WO2001032910A3 (fr) 27 proteines humaines secretees
WO1998045712A3 (fr) 20 proteines humaines secretees
CY1111950T1 (el) 32 ανθρωπινες εκκρινομενες πρωτεϊνες
WO2001012776A3 (fr) 18 proteines secretees humaines
WO2001034768A3 (fr) 15 proteines secretees humaines
WO2000017222A8 (fr) 31 proteines humaines secretees
WO2000077026A8 (fr) 49 proteines secretees humaines
WO2000052136A3 (fr) Enzymes de glycosylation humaines
WO2000063230A3 (fr) 49 proteines secretees humaines
WO2000073323A3 (fr) Polynucléotides et polypeptides adam
WO2001062891A3 (fr) 207 proteines humaines secretees
EP1042342A4 (fr) 53 proteines secretees humaines
WO2000058339A3 (fr) 50 proteines humaines secretees
WO2001012775A3 (fr) 25 proteines secretees humaines
WO2000061624A8 (fr) 48 proteines secretees humaines
WO2000043495A3 (fr) Proteines humaines secretees (33)
WO2000061596A8 (fr) 50 proteines humaines secretees
WO2003052377A9 (fr) 41 proteines secretees humaines
WO2002099066A3 (fr) 20 proteines humaines secretees

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 608040

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref document number: 2368469

Country of ref document: CA

Ref country code: CA

Ref document number: 2368469

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2000918298

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000918298

Country of ref document: EP